This approval marks another significant step forward," said Levi Garraway, M.D., Ph.D., Chief Medical Officer and Head of Global Product Development, Roche. "The Evrysdi tablet combines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback